Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Medtronic plcMDT · Entity 2888 | EVP & Pres Neuroscience | May 26, 2026 | May 28, 2026 |
| MiniMed Group, Inc.MMED · Entity 3758 | Director | March 06, 2026 | March 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Medtronic plc
Report date May 26, 2026 · Filed May 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 82,183 |
Reported balance
After 2026-05-26 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-26 · Exercise / conversion · Acquired 26,907 · Balance 82,183 F1: Represents shares issued upon the settlement of performance-vesting share units granted on July 31, 2023, based on performance as certified on May 26, 2026. F2: Includes 527 shares acquired through dividend reinvestment since the last report filed by the reporting person. |
| Performance Share UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-05-26 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-26 · Exercise / conversion · Disposed 24,214 · Balance 0 F3: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4: The performance share units vested on April 24, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares issued upon the settlement of performance-vesting share units granted on July 31, 2023, based on performance as certified on May 26, 2026.
F2: Includes 527 shares acquired through dividend reinvestment since the last report filed by the reporting person.
F3: Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
F4: The performance share units vested on April 24, 2026.
MiniMed Group, Inc.
Report date March 06, 2026 · Filed March 06, 2026
This filing explicitly reported no securities owned.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 26, 2026 Filed May 28, 2026 20:26 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionPerformance Share Unit · Derivative | 24,214 | $0.00 | $0.00 |
DisclosureSEC source: 0001473812-26-000002 · wk-form4_1779999981.xml · derivative · entry 2 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 24,214 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4 · derivative.exercise_date: The performance share units vested on April 24, 2026. F4 · derivative.expiration_date: The performance share units vested on April 24, 2026. Read SEC document |
| May 26, 2026 Filed May 28, 2026 20:26 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 26,907 | $0.00 | $0.00 |
DisclosureSEC source: 0001473812-26-000002 · wk-form4_1779999981.xml · nonDerivative · entry 1 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,183 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares issued upon the settlement of performance-vesting share units granted on July 31, 2023, based on performance as certified on May 26, 2026. F2 · balance_after: Includes 527 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 21:18 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 439 | $99.87 | $43,842.93 |
DisclosureSEC source: 0001473812-25-000004 · wk-form4_1766006325.xml · nonDerivative · entry 1 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,749 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I due to reporting person's retirement eligibility. F2 · balance_after: Includes 251 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:20 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionPerformance Share Units · Derivative | 15,249 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000133 · wk-form4_1754338822.xml · derivative · entry 4 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Performance Share Unit · 15,249 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F5 · derivative.exercise_date: The performance share units vested on August 1, 2025. F5 · derivative.expiration_date: The performance share units vested on August 1, 2025. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:20 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 3,850 | $89.34 | $343,959.00 |
DisclosureSEC source: 0001613103-25-000133 · wk-form4_1754338822.xml · nonDerivative · entry 3 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,937 F3 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:20 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 7,744 | $89.34 | $691,848.96 |
DisclosureSEC source: 0001613103-25-000133 · wk-form4_1754338822.xml · nonDerivative · entry 2 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,787 F2 · shares: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 1, 2025. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:20 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 15,249 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000133 · wk-form4_1754338822.xml · nonDerivative · entry 1 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,531 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 1, 2022 and earned dividend equivalents. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:29 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 69,005 | $0.00 Strike: $91.97 | $0.00 |
DisclosureSEC source: 0001613103-25-000117 · wk-form4_1753907342.xml · derivative · entry 3 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,005 Underlying: Ordinary Shares · 69,005 shares Expires 2035-07-28 F6 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:29 UTC | Medtronic plc MDT · Entity 2888 | GrantPerformance Share Units · Derivative | 24,465 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000117 · wk-form4_1753907342.xml · derivative · entry 2 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,465 Underlying: Performance Share Unit · 24,465 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4 · derivative.exercise_date: Represents performance share units for which certain performance conditions will have been satisfied on April 28, 2028. F4 · derivative.expiration_date: Represents performance share units for which certain performance conditions will have been satisfied on April 28, 2028. F5 · derivative.underlying_shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 24,465 shares will be issued. If maximum performance metrics are achieved, 48,930 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:29 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 9,786 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000117 · wk-form4_1753907342.xml · nonDerivative · entry 1 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,282 F1 · shares: Represents restricted stock units that vest 100% on the third anniversary of the date of grant. F2 · balance_after: Includes 517 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| January 24, 2025 Filed Jan 27, 2025 22:35 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 12,437 | $0.00 Strike: $78.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000009 · wk-form4_1738017322.xml · derivative · entry 3 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 12,437 shares Expires 2025-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 24, 2025 Filed Jan 27, 2025 22:35 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 12,437 | $90.00 | $1,119,330.00 |
DisclosureSEC source: 0001613103-25-000009 · wk-form4_1738017322.xml · nonDerivative · entry 2 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,979 Read SEC document |
| January 24, 2025 Filed Jan 27, 2025 22:35 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 12,437 | $78.00 | $970,086.00 |
DisclosureSEC source: 0001613103-25-000009 · wk-form4_1738017322.xml · nonDerivative · entry 1 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,416 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 271 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 21:48 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,850 | $0.00 Strike: $74.84 | $0.00 |
DisclosureSEC source: 0001613103-25-000003 · wk-form4_1736545728.xml · derivative · entry 4 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,850 shares Expires 2025-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 21:48 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 3,000 | $80.41 | $241,230.00 |
DisclosureSEC source: 0001613103-25-000003 · wk-form4_1736545728.xml · nonDerivative · entry 3 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,708 Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 21:48 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 6,850 | $80.41 | $550,808.50 |
DisclosureSEC source: 0001613103-25-000003 · wk-form4_1736545728.xml · nonDerivative · entry 2 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,708 Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 21:48 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 6,850 | $74.84 | $512,654.00 |
DisclosureSEC source: 0001613103-25-000003 · wk-form4_1736545728.xml · nonDerivative · entry 1 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,558 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 16, 2024 Filed Dec 17, 2024 22:00 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 645 | $82.48 | $53,199.60 |
DisclosureSEC source: 0001613103-24-000179 · wk-form4_1734472828.xml · nonDerivative · entry 1 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,708 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I due to reporting person's retirement eligibility. F2 · balance_after: Includes 247 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 22:16 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionPerformance Share Units · Derivative | 5,311 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-24-000120 · wk-form4_1722982576.xml · derivative · entry 4 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Performance Share Units · 5,311 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F5 · derivative.exercise_date: The performance share units vested on August 2, 2024. F5 · derivative.expiration_date: The performance share units vested on August 2, 2024. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 22:16 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 2,701 | $81.51 | $220,158.51 |
DisclosureSEC source: 0001613103-24-000120 · wk-form4_1722982576.xml · nonDerivative · entry 3 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,106 F3 · shares: Represents shares withheld for taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 22:16 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 2,362 | $81.51 | $192,526.62 |
DisclosureSEC source: 0001613103-24-000120 · wk-form4_1722982576.xml · nonDerivative · entry 2 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,807 F2 · shares: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 2, 2024. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 22:16 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 5,311 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-24-000120 · wk-form4_1722982576.xml · nonDerivative · entry 1 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,169 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 2, 2021 and earned dividend equivalents. Read SEC document |
| July 29, 2024 Filed Aug 1, 2024 00:08 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 106,260 | $0.00 Strike: $80.00 | $0.00 |
DisclosureSEC source: 0001613103-24-000096 · wk-form4_1722470893.xml · derivative · entry 3 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,260 Underlying: Ordinary Shares · 106,260 shares Expires 2034-07-29 F6 · derivative.exercise_date: These options became exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| July 29, 2024 Filed Aug 1, 2024 00:08 UTC | Medtronic plc MDT · Entity 2888 | GrantPerformance Share Unit · Derivative | 35,938 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-24-000096 · wk-form4_1722470893.xml · derivative · entry 2 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,938 Underlying: Performance Share Units · 35,938 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share unit represented a contingent right to receive one share of Medtronic common stock. F4 · derivative.exercise_date: Vests on July 29, 2027. F4 · derivative.expiration_date: Vests on July 29, 2027. F5 · derivative.underlying_shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 35,983 shares will be issued. If maximum performance metrics are achieved, 71,876 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. Read SEC document |
| July 29, 2024 Filed Aug 1, 2024 00:08 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 14,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-24-000096 · wk-form4_1722470893.xml · nonDerivative · entry 1 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,858 F1 · shares: The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. F2 · balance_after: Includes 573 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| December 19, 2023 Filed Dec 20, 2023 16:41 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 4,997 | $82.17 | $410,603.49 |
DisclosureSEC source: 0001613103-23-000166 · wk-form4_1703090489.xml · nonDerivative · entry 1 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,910 F1 · shares: This transaction was made pursuant to Mr. Wall's existing Rule 10b5-1 plan. Read SEC document |
| December 08, 2023 Filed Dec 12, 2023 19:54 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 435 | $79.27 | $34,482.45 |
DisclosureSEC source: 0001613103-23-000163 · wk-form4_1702410865.xml · nonDerivative · entry 1 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,907 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I due to reporting person's retirement eligibility. F2 · balance_after: Includes 769 units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| August 14, 2023 Filed Aug 16, 2023 21:16 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 1,000 | $83.38 | $83,380.00 |
DisclosureSEC source: 0001613103-23-000113 · wk-form4_1692220574.xml · nonDerivative · entry 1 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,573 F1 · shares: This transaction was made pursuant to Mr. Wall's existing Rule 10b5-1 plan. Read SEC document |
| August 03, 2023 Filed Aug 8, 2023 00:22 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionPerformance Share Units · Derivative | 5,168 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000100 · wk-form4_1691454149.xml · derivative · entry 3 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Performance Share Units · 5,168 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each performance share unit represented a contingent right to receive one share of Medtronic common stock. F4 · price: Each performance share unit represented a contingent right to receive one share of Medtronic common stock. F5 · derivative.exercise_date: The performance share units vested on August 3, 2023. F5 · derivative.expiration_date: The performance share units vested on August 3, 2023. Read SEC document |
| August 03, 2023 Filed Aug 8, 2023 00:22 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 4,284 | $84.49 | $361,955.16 |
DisclosureSEC source: 0001613103-23-000100 · wk-form4_1691454149.xml · nonDerivative · entry 2 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,573 F3 · shares: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units and restricted stock units that vested on August 3, 2023. Read SEC document |
| August 03, 2023 Filed Aug 8, 2023 00:22 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 5,168 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000100 · wk-form4_1691454149.xml · nonDerivative · entry 1 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,857 F1 · shares: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on October 9, 2020 and earned dividend equivalents. F2 · balance_after: Includes 55 shares representing earned dividend equivalents upon the settlement of restricted stock units that vested on August 3, 2023 and were previously reported on Table 1. Read SEC document |
| July 31, 2023 Filed Aug 3, 2023 00:13 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 68,196 | $0.00 Strike: $87.76 | $0.00 |
DisclosureSEC source: 0001613103-23-000082 · wk-form4_1691021627.xml · derivative · entry 3 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,196 Underlying: Ordinary Shares · 68,196 shares Expires 2033-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted beginning on the first anniversary of the grant. Read SEC document |
| July 31, 2023 Filed Aug 3, 2023 00:13 UTC | Medtronic plc MDT · Entity 2888 | GrantPerformance Share Units · Derivative | 24,214 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000082 · wk-form4_1691021627.xml · derivative · entry 2 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,214 Underlying: Performance Share Unit · 24,214 shares Expires not disclosed F2 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F3 · shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 24,214 shares will be issued. If maximum performance metrics are achieved, 48,428 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. F4 · derivative.exercise_date: Vests on July 31, 2026. F4 · derivative.expiration_date: Vests on July 31, 2026. Read SEC document |
| July 31, 2023 Filed Aug 3, 2023 00:13 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 9,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000082 · wk-form4_1691021627.xml · nonDerivative · entry 1 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,634 F1 · shares: Restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. Read SEC document |
| July 14, 2023 Filed Jul 18, 2023 20:16 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 2,000 | $87.97 | $175,940.00 |
DisclosureSEC source: 0001613103-23-000054 · wk-form4_1689711392.xml · nonDerivative · entry 1 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,948 F1 · kind: This transaction was made pursuant to the reporting person's existing Rule 10b5-1 plan. F2 · balance_after: Includes 478 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 21:47 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 337 | $79.04 | $26,636.48 |
DisclosureSEC source: 0001127602-22-027197 · form4.xml · nonDerivative · entry 1 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,470 F1 · balance_after: This balance increased by 161 shares due to exempt acquisitions through dividend reinvestment. F2 · balance_after: The reported transaction involved the withholding of 337 shares of stock issuable upon the early vesting of an equal number of restricted stock units to pay taxes associated with the reporting person becoming retirement eligible. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 21:50 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 59,433 | $0.00 Strike: $93.08 | $0.00 |
DisclosureSEC source: 0001127602-22-020428 · form4.xml · derivative · entry 3 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,433 Underlying: Ordinary Shares · 59,433 shares Expires 2032-08-01 F5 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 21:50 UTC | Medtronic plc MDT · Entity 2888 | GrantPerformance Share Units · Derivative | 18,802 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-020428 · form4.xml · derivative · entry 2 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,802 Underlying: Performance Share Units · 18,802 shares Expires not disclosed F2 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F3 · shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 18,802 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. F4 · derivative.exercise_date: Vests on August 1, 2025. F4 · derivative.expiration_date: Vests on August 1, 2025. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 21:50 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 7,521 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-020428 · form4.xml · nonDerivative · entry 1 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,646 F1 · shares: The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. Read SEC document |
| July 29, 2022 Filed Aug 2, 2022 21:53 UTC | Medtronic plc MDT · Entity 2888 | Disposition to issuerOrdinary Shares | 7,493 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-020233 · form4.xml · nonDerivative · entry 1 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,125 F1 · shares: Represents shares of performance-vesting restricted stock granted in July 2019 and earned dividend equivalent units that have been forfeited based on the Company's failure to meet the cumulative three year non-GAAP diluted earnings per share ("EPS") growth performance target. F2 · balance_after: This balance increased by 367 shares due to exempt acquisitions through dividend reinvestment. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 23:06 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 238 | $122.98 | $29,269.24 |
DisclosureSEC source: 0001127602-21-028743 · form4.xml · nonDerivative · entry 1 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,251 F1 · balance_after: The reported transaction involved the withholding of 238 shares of stock issuable upon the early vesting of an equal number of restricted stock units to pay taxes associated with the reporting person becoming retirement eligible. F2 · balance_after: This balance increased by 94 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 22:28 UTC | Medtronic plc MDT · Entity 2888 | GrantPerformance Share Units · Derivative | 13,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-023108 · form4.xml · derivative · entry 5 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,333 Underlying: Performance Share Units · 13,333 shares Expires not disclosed F5 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F6 · shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 13,333 shares will be issued. The actual number of shares to be issued could range from a low of 2,667 shares at minimum performance to a high of 26,666 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares. F7 · derivative.exercise_date: Vests on August 2, 2024. F7 · derivative.expiration_date: Vests on August 2, 2024. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 22:28 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 1,085 | $0.00 Strike: $131.26 | $0.00 |
DisclosureSEC source: 0001127602-21-023108 · form4.xml · derivative · entry 4 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,085 Underlying: Ordinary Shares · 1,085 shares Expires 2031-08-02 F4 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 22:28 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 45,565 | $0.00 Strike: $131.26 | $0.00 |
DisclosureSEC source: 0001127602-21-023108 · form4.xml · derivative · entry 3 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,565 Underlying: Ordinary Shares · 45,565 shares Expires 2031-08-02 F4 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 22:28 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 5,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-023108 · form4.xml · nonDerivative · entry 2 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,395 F3 · kind: The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 22:28 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 1,482 | $131.31 | $194,601.42 |
DisclosureSEC source: 0001127602-21-023108 · form4.xml · nonDerivative · entry 1 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,062 F1 · balance_after: This amount has been adjusted to correct a mathematical error in exempt transactions such as dividend reinvestment. F2 · balance_after: This balance increased by 83 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| June 21, 2021 Filed Jun 22, 2021 21:58 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 115 | $123.50 | $14,202.50 |
DisclosureSEC source: 0001127602-21-020516 · form4.xml · nonDerivative · entry 3 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,602 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 18, 2021 Filed Jun 22, 2021 21:58 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,168 | $0.00 Strike: $74.84 | $0.00 |
DisclosureSEC source: 0001127602-21-020516 · form4.xml · derivative · entry 4 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,850 Underlying: Ordinary Shares · 1,168 shares Expires 2025-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · derivative.exercise_date: This option became exercisable on June 29, 2018, subject to Medtronic plc's achievement of a pre-specified cash Earnings Per Share Growth Rate for fiscal years 2016 through 2018. Read SEC document |
| June 18, 2021 Filed Jun 22, 2021 21:58 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 938 | $123.23 | $115,589.74 |
DisclosureSEC source: 0001127602-21-020516 · form4.xml · nonDerivative · entry 2 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,717 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 18, 2021 Filed Jun 22, 2021 21:58 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 1,168 | $74.84 | $87,413.12 |
DisclosureSEC source: 0001127602-21-020516 · form4.xml · nonDerivative · entry 1 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,655 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.